share_log
Reuters ·  04/29 08:30

Atossa Therapeutics Announces Expanded Research Agreement With Weill Cornell Medicine to Further Evaluate Synergy Between Antibody Drug Conjugates (Adcs) and (Z)-Endoxifen

Atossa Therapeutics宣布扩大与威尔康奈尔医药的研究协议,以进一步评估抗体药物偶联物(Adcs)和(Z)-恩多昔芬之间的协同作用

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发